Dormant
PRGS · Progress Software Corporation
Last analysed ·
Resolved Graded and closed 2026-08-14 at medium conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
Disciplined software roll-up ("Total Growth Strategy") re-rated by a fresh catalyst cluster: Q2 beat + FY guide raise (2026-06-30) and the $400M Domo buy (2026-07-22). Special-situations theme active, but a maturing low-beta compounder — structurally supported on a pullback to the breakout retest, rather than on the +11.7% extension.
Kill line
A weekly close below $37 fills the 2026-07-01 post-earnings gap and voids the breakout shelf; a Domo deal break or the M&A-special-situations theme flipping to saturated with a dry target pipeline confirms the re-rating has stalled.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for PRGS —
As of 20 September 2026, the latest FrontierPicks analysis for Progress Software Corporation (PRGS): Disciplined software roll-up ("Total Growth Strategy") re-rated by a fresh catalyst cluster: Q2 beat + FY guide raise (2026-06-30) and the $400M Domo buy (2026-07-22). Special-situations theme active, but a maturing low-beta compounder — structurally supported on a pullback to the breakout retest, rather than on the +11.7% extension.
Kill line: A weekly close below $37 fills the 2026-07-01 post-earnings gap and voids the breakout shelf; a Domo deal break or the M&A-special-situations theme flipping to saturated with a dry target pipeline confirms the re-rating has stalled.
Next dated event on file: — catalyst in 10d.
Current Thesis
Progress Software’s acquisition-led earnings story faces a September test: the quarterly results and completion of the Domo purchase must support the re-rating before the market loses the $37 weekly-close threshold. The operating hurdle is fiscal third-quarter revenue of at least $250.0 million and adjusted earnings per share (EPS) of at least $1.59, the upper endpoints of guidance issued on 2026-06-30. These are research benchmarks; management’s 2026-07-22 statement anticipated results ‘within or above the high end,’ which is less categorical than a guaranteed minimum. Progress’s filed announcement.
The material calendar change since the September note is confirmation: Progress announced on 2026-09-16 that both the results release and conference call will occur on 2026-09-30. The release follows the market close. Company scheduling announcement.
The narrative is maturing — this is an inference from the supplied price record, with the reference close retreating from $44.05 on 2026-09-04 to $40.11 on 2026-09-18 while the existing earnings-and-acquisition sequence remains unresolved. This classification does not establish declining institutional participation or crowded ownership.
Bullish and bearish views on Progress Software Corporation
The model's bull view on Progress Software Corporation (PRGS), in brief: Earnings support preceded the acquisition. The bear view: Reported and adjusted guidance diverged. Both cases follow in full.
Bull Case
- Earnings support preceded the acquisition. Progress’s 2026-06-30 results reported fiscal second-quarter revenue of $253.465 million and adjusted EPS of $1.62. The same update raised fiscal 2026 adjusted EPS guidance to $6.09–$6.21 and revenue guidance to $990.0 million–$1.002 billion. Those reported results support the earnings argument independently of anticipated Domo integration benefits.
- A regulatory condition has cleared. Domo’s 2026-08-31 update disclosed early termination of the Hart-Scott-Rodino antitrust waiting period on 2026-08-25 and an expected transaction close by the end of September. Remaining closing conditions still applied. Domo transaction update.
- The acquisition thesis is specific. The 2026-07-22 agreement covers Domo’s artificial-intelligence and data-platform business for $400 million in cash. Progress described the purchase as an extension of its acquisition strategy; completion establishes ownership of the business, while subsequent financial reporting must establish its contribution. Filed transaction announcement.
Bear Case
- Reported and adjusted guidance diverged. On 2026-06-30, Progress lowered fiscal 2026 earnings guidance under generally accepted accounting principles (GAAP) to $1.60–$1.74 per share while raising adjusted guidance. A further reduction below the GAAP guidance floor would weaken the claim that improving adjusted earnings capture improving total economics.
- The market has surrendered momentum. The supplied 2026-09-18 price record places the shares 14.4% below their $46.87 trailing-year high. The 14-period relative strength index (RSI) measured 36.7, compared with 54.8 in the 2026-09-04 record. These observations establish weaker price momentum, without identifying who reduced exposure.
- Expected completion is still conditional. Domo’s 2026-08-31 statement retained closing conditions despite antitrust clearance. An announced delay beyond September would contradict the near-term completion expectation; termination would break the acquisition leg outright. Domo transaction update.
Setup & Price Structure
The supplied split- and dividend-adjusted record shows a $40.11 close on 2026-09-18 and a three-month price increase of 45.0%. That positive trailing return coexists with the weaker recent close and RSI readings; it does not establish that a new base has formed.
The $37 weekly-close threshold remains the research invalidation level published in the 2026-09-06 note. The supplied observations do not independently establish the precise boundaries of the July earnings gap, so the threshold is retained without repeating the earlier gap-fill claim. The $46.87 trailing-year high, measured as of 2026-09-18, remains a market reference rather than a forecast.
The confirmed 2026-09-30 earnings event concentrates near-term uncertainty. Current moving-average values, trading-volume comparisons, short interest and comprehensive ownership data are missing. The available evidence therefore supports no conclusion about crowded positioning or expanding participation.
Catalyst Calendar (next 30 days)
- 2026-09-30 — Fiscal third-quarter results and call. Progress confirmed the date on 2026-09-16. The report tests the June guidance endpoints and provides an opportunity to update acquisition timing and financial expectations. Company announcement.
- ~2026-09-30, est. Domo completion window. Domo’s 2026-08-31 statement expects closing by the end of September; this is a deadline expectation, not an appointed closing day. A completion announcement or revised timing would resolve this part of the thesis. Domo update.
What Would Change Our Mind
Loss of the retained September research threshold ends the price-supported re-rating thesis: a weekly close below $37 is the observable invalidation. The case resolves positively if the September report reaches the $250.0 million revenue and $1.59 adjusted EPS research hurdles and Domo closes by the end of September before that price condition occurs.
Revenue or adjusted EPS below those hurdles would fail the operating test even if results remained inside the original 2026-06-30 guidance ranges. A transaction termination would remove the acquisition catalyst; an announced postponement beyond September would invalidate the published completion timetable.
Correlation Notes
This remains a single-name earnings-and-acquisition setup: the coverage context accompanying the 2026-09-18 price record identifies no active theme cluster containing Progress. No synchronized peer-return series is supplied, so a low-beta characterization or measured enterprise-software correlation is unsupported. The software and acquisition tags describe the business exposure; they do not establish a shared market bid.
Notes
- Fiscal year ends November 30; Q3 FY2026 covers the quarter ended 2026-08-31. The company scheduled its call for 2026-09-30 while data screens list the release as 2026-09-28 or 09-29.
- The Domo transaction is an asset purchase, not a merger: no target shareholder vote (controlling-holder written consent, Schedule 14C), and the Domo shell stays listed and re-tickers after close.
- The GAAP/adjusted EPS gap is acquisition amortization and integration expense, structural to a roll-up. Adjusted free cash flow and net leverage are the metrics that track the model.
- 2026 insider open-market sales disclosed to date ran through Rule 10b5-1 plans adopted 2026-01-23 and 2026-02-04, so they are scheduled rather than discretionary.
- A blackout window runs from the 2026-08-31 fiscal quarter end into the results date, so no company-dated disclosure is scheduled in between except 8-Ks on the Domo deal.
Related · shared themes
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.
DSGR
Distribution Solutions Group, Inc.
Distribution Solutions Group’s $35.00 cash acquisition remains a completion thesis, with the minority vote and closing settling the case. HSR clearance occurred on 2026-08-20; a daily close below $33.50 invalidates the price thesis.
ATKR
Atkore Inc.
Atkore's $95.00 cash-merger thesis now turns on the October 7 shareholder vote and remaining approvals after September 14 US antitrust clearance. Completion before a weekly close below $88 constitutes success; termination negates the case.